{"id":"https://openalex.org/W2888393149","doi":"https://doi.org/10.1001/jama.2018.11439","title":"Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents","display_name":"Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents","publication_year":2018,"publication_date":"2018-08-21","ids":{"openalex":"https://openalex.org/W2888393149","doi":"https://doi.org/10.1001/jama.2018.11439","mag":"2888393149","pmid":"https://pubmed.ncbi.nlm.nih.gov/30140875","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6142946"},"language":"en","primary_location":{"id":"doi:10.1001/jama.2018.11439","doi":"https://doi.org/10.1001/jama.2018.11439","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jama.2018.11439","pdf_url":"https://jamanetwork.com/journals/jama/articlepdf/2697695/jama_sacks_2018_oi_180085.pdf","source":{"id":"https://openalex.org/S172573765","display_name":"JAMA","issn_l":"0002-9955","issn":["0002-9955","0098-7484","1538-3598","2376-8118"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://jamanetwork.com/journals/jama/articlepdf/2697695/jama_sacks_2018_oi_180085.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003249779","display_name":"Chana A. Sacks","orcid":"https://orcid.org/0000-0002-6999-3173","observed_orcids":["https://orcid.org/0000-0002-6999-3173"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Chana A. Sacks","raw_affiliation_strings":["Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033279765","display_name":"ChangWon C. Lee","orcid":"https://orcid.org/0000-0001-7534-0526","observed_orcids":["https://orcid.org/0000-0001-7534-0526"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"ChangWon C. Lee","raw_affiliation_strings":["Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074257304","display_name":"Aaron Seth Kesselheim","orcid":"https://orcid.org/0000-0002-8867-2666","observed_orcids":["https://orcid.org/0000-0002-8867-2666"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron S. Kesselheim","raw_affiliation_strings":["Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036726043","display_name":"Jerry Avorn","orcid":"https://orcid.org/0000-0003-0255-2346","observed_orcids":["https://orcid.org/0000-0003-0255-2346"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jerry Avorn","raw_affiliation_strings":["Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5003249779"],"corresponding_institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"],"apc_list":null,"apc_paid":null,"fwci":11.2411,"has_fulltext":true,"cited_by_count":48,"citation_normalized_percentile":{"value":0.98276377,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"320","issue":"7","first_page":"650","last_page":"650"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/generic-drugs","display_name":"generic drugs","score":0.734000027179718},{"id":"https://openalex.org/keywords/medicare-spending","display_name":"Medicare spending","score":0.7919999957084656},{"id":"https://openalex.org/keywords/prescription-drug-costs","display_name":"prescription drug costs","score":0.7710000276565552},{"id":"https://openalex.org/keywords/generic-substitution","display_name":"generic substitution","score":0.5929999947547913},{"id":"https://openalex.org/keywords/drug-cost-savings","display_name":"drug cost savings","score":0.5339999794960022},{"id":"https://openalex.org/keywords/medicare-part-d","display_name":"Medicare Part D","score":0.8790000081062317},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.4300000071525574},{"id":"https://openalex.org/keywords/drug-utilization-patterns","display_name":"drug utilization patterns","score":0.3190000057220459}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.848493218421936},{"id":"https://openalex.org/C2992181568","wikidata":"https://www.wikidata.org/wiki/Q431289","display_name":"Brand names","level":2,"score":0.8308588266372681},{"id":"https://openalex.org/C2776396487","wikidata":"https://www.wikidata.org/wiki/Q506319","display_name":"Generic drug","level":3,"score":0.5194315910339355},{"id":"https://openalex.org/C2776291444","wikidata":"https://www.wikidata.org/wiki/Q6806635","display_name":"Medicare Part D","level":4,"score":0.4560404419898987},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.23521628975868225},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.21796807646751404},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.18503829836845398},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.15681010484695435},{"id":"https://openalex.org/C2778858636","wikidata":"https://www.wikidata.org/wiki/Q1643563","display_name":"Prescription drug","level":3,"score":0.12369236350059509},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.07143411040306091}],"mesh":[{"descriptor_ui":"D005102","descriptor_name":"Health Expenditures","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D054524","descriptor_name":"Medicare Part D","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D055553","descriptor_name":"Prescription Drugs","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1001/jama.2018.11439","doi":"https://doi.org/10.1001/jama.2018.11439","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jama.2018.11439","pdf_url":"https://jamanetwork.com/journals/jama/articlepdf/2697695/jama_sacks_2018_oi_180085.pdf","source":{"id":"https://openalex.org/S172573765","display_name":"JAMA","issn_l":"0002-9955","issn":["0002-9955","0098-7484","1538-3598","2376-8118"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5364632","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6142946","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6142946","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6142946","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"Text"},{"id":"pmid:30140875","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30140875","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1001/jama.2018.11439","doi":"https://doi.org/10.1001/jama.2018.11439","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jama.2018.11439","pdf_url":"https://jamanetwork.com/journals/jama/articlepdf/2697695/jama_sacks_2018_oi_180085.pdf","source":{"id":"https://openalex.org/S172573765","display_name":"JAMA","issn_l":"0002-9955","issn":["0002-9955","0098-7484","1538-3598","2376-8118"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320311571","display_name":"Laura and John Arnold Foundation","ror":"https://ror.org/04hqxh742"},{"id":"https://openalex.org/F4320315055","display_name":"Engelberg Foundation","ror":"https://ror.org/02hrbh596"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2888393149.pdf","grobid_xml":"https://content.openalex.org/works/W2888393149.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W63425872","https://openalex.org/W324102958","https://openalex.org/W2006584351","https://openalex.org/W2028591881","https://openalex.org/W2030068099","https://openalex.org/W2069184139","https://openalex.org/W2070153213","https://openalex.org/W2071521423","https://openalex.org/W2112204400","https://openalex.org/W2122833169","https://openalex.org/W2138946218","https://openalex.org/W2158234033","https://openalex.org/W2170397284","https://openalex.org/W2171471755","https://openalex.org/W2218679182","https://openalex.org/W2230640864","https://openalex.org/W2294748937","https://openalex.org/W2347207353","https://openalex.org/W2408515227","https://openalex.org/W2513403311","https://openalex.org/W2522162683","https://openalex.org/W2581578406","https://openalex.org/W2594329719","https://openalex.org/W2724972568","https://openalex.org/W2738615667","https://openalex.org/W2790706219","https://openalex.org/W2805026867","https://openalex.org/W2980918812","https://openalex.org/W4248398323"],"related_works":["https://openalex.org/W4253548384","https://openalex.org/W2783268636","https://openalex.org/W2069184139","https://openalex.org/W4412764282","https://openalex.org/W1484493227","https://openalex.org/W2067944869","https://openalex.org/W4200139290","https://openalex.org/W2267185358","https://openalex.org/W2793250605","https://openalex.org/W3159893228"],"abstract_inverted_index":{"Importance:":[0],"Brand-name":[1,88],"combination":[2,48,89,104,133,156,212,255,297,355,406],"drugs":[3,90,112,134,335],"can":[4],"be":[5,29],"more":[6,434],"expensive":[7],"than":[8,342],"the":[9,16,40,65,76,82,126,136,150,193,210,218,222,239,253,261,265,282,295,303,307,325,329,343,347,351,359,363,380,391,394,397,409,416,447],"sum":[10],"of":[11,45,51,69,75,235,278,320,419],"their":[12],"components,":[13],"especially":[14],"when":[15],"constituent":[17],"products":[18,213,256,298,356],"are":[19],"available":[20,108,166,195,357],"as":[21,110,167,196],"generic":[22,32,52,97,111,116,146,168,176,187,197,223,240,266,285,308,330,381,413,425],"medications.":[23],"The":[24,122],"potential":[25],"savings":[26,445],"that":[27,79,91,139,396],"could":[28,367],"achieved":[30],"using":[31,64],"components":[33],"is":[34,231,274,316],"not":[35],"known.":[36],"Objective:":[37],"To":[38],"estimate":[39],"additional":[41],"cost":[42],"to":[43,442],"Medicare":[44,66,130,206,249,291,365,398,448],"prescribing":[46],"brand-name":[47,132,155,211,254,296,348,405],"medications":[49,78,105,152,157,169,198,407],"instead":[50],"constituents.":[53],"Design,":[54],"Setting,":[55],"and":[56,120,135,184,217,260,302,377,387,408,427,433],"Participants:":[57],"Retrospective":[58],"analysis":[59],"for":[60,81,221,264,306,328,332,346,412,415],"2011":[61,376],"through":[62,430],"2016":[63,208,251,293,378],"data":[67],"set":[68],"Part":[70],"D":[71],"beneficiaries":[72],"prescribed":[73],"any":[74],"1500":[77,151],"accounted":[80],"highest":[83],"total":[84,203,246,288],"spending":[85,204,220,247,263,289,305,327,345,366,403,411],"in":[86,207,250,292,446],"2015.":[87],"had":[92,383],"identical":[93,171,200],"or":[94,113],"therapeutically":[95,114,185,283],"equivalent":[96,115,186,284],"constituents":[98,107,165,177,194,224,241,267,309,331,382,414],"were":[99,158],"included.":[100],"Exposures:":[101],"Brand-name,":[102],"oral":[103],"with":[106],"either":[109],"substitutes.":[117],"Main":[118],"Outcomes":[119],"Measures:":[121],"estimated":[123,137,219,233,262,276,304,318,326,344,371,410],"difference":[124,234,277,319,392],"between":[125,375,393],"amount":[127,138,395],"spent":[128,143],"by":[129,205,248,290],"on":[131,144,209,252,294,404],"would":[140,225,268,310,336],"have":[141,226,269,311,337,368],"been":[142,227,270,312,338,369,384],"substitutable":[145],"components.":[147],"Results:":[148],"Among":[149],"evaluated,":[153],"29":[154,334],"separated":[159],"into":[160],"3":[161],"mutually":[162],"exclusive":[163],"categories:":[164],"at":[170,178,199,242],"doses":[172,180,201,244,420],"(n":[173,181,189],"=":[174,182,190],"20),":[175],"different":[179,243],"3),":[183],"substitutes":[188,286],"6).":[191],"For":[192,238,281,350],"category,":[202,245,287],"was":[214,257,299,421],"$303":[215],"million":[216,259,301,340],"$68":[228],"million,":[229,272,314],"which":[230,273,315],"an":[232,275,317,370],"$235":[236],"million.":[237,280,322,423],"$232":[258],"$13":[271],"$219":[279],"$491":[300],"$20":[313],"$471":[321],"In":[323,389],"2016,":[324,390],"these":[333],"$925":[339,422],"less":[341],"combinations.":[349],"10":[352],"most":[353],"costly":[354],"during":[358],"entire":[360],"study":[361],"period,":[362],"listed":[364],"$2.7":[372],"billion":[373],"lower":[374],"if":[379],"prescribed.":[385],"Conclusions":[386],"Relevance:":[388],"drug":[399,449],"benefit":[400,450],"program":[401],"reported":[402],"same":[417],"number":[418],"Promoting":[424],"substitution":[426,436],"therapeutic":[428],"interchange":[429],"prescriber":[431],"education":[432],"rational":[435],"policies":[437],"may":[438],"offer":[439],"important":[440],"opportunities":[441],"achieve":[443],"substantial":[444],"program.":[451]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-08-31T00:00:00"}